ABHD12 contributes to tumorigenesis and sorafenib resistance by preventing ferroptosis in hepatocellular carcinoma

ABHD12 contributes to tumorigenesis and sorafenib resistance by preventing ferroptosis in hepatocellular carcinoma

Summary: Sorafenib induces ferroptosis, making it a useful treatment against advanced liver hepatocellular carcinoma (LIHC). However, sorafenib resistance is extremely common among LIHC patients. Here, we used a comprehensive approach to investigate the effects of ABHD12, which regulates tumorigenes...

Full description

Bibliographic Details
Main Authors:	Mengxing Cai, Jingwen Luo, Chunxiu Yang, Xiaopeng Yang, Cheng Zhang, Lixin Ma, Yibin Cheng
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	iScience
Subjects:	Pharmacology Natural sciences Biological sciences Systems biology Cancer systems biology Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589004223024173

Similar Items

AID-induced CXCL12 upregulation enhances castration-resistant prostate cancer cell metastasis by stabilizing β-catenin expression
by: Qi Li, et al.
Published: (2023-12-01)

Genomic and experimental evidence that ALKATI does not predict single agent sensitivity to ALK inhibitors
by: Haider Inam, et al.
Published: (2021-11-01)

Tumor microenvironment mimicking 3D models unveil the multifaceted effects of SMAC mimetics
by: Catarina Pinto, et al.
Published: (2023-04-01)

Development of OX40 agonists for canine cancer immunotherapy
by: Damien Ruiz, et al.
Published: (2022-10-01)

Mitochondrial UQCC3 controls embryonic and tumor angiogenesis by regulating VEGF expression
by: Guimin Zhang, et al.
Published: (2023-08-01)

NatD epigenetically activates FOXA2 expression to promote breast cancer progression by facilitating MMP14 expression
by: Mengying Xing, et al.
Published: (2024-02-01)

A small-molecule degrader selectively inhibits the growth of ALK-rearranged lung cancer with ceritinib resistance
by: Xin Li, et al.
Published: (2024-02-01)

Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD
by: Fangzhi Yue, et al.
Published: (2023-12-01)

Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
by: Gabriela Reyes-Castellanos, et al.
Published: (2023-06-01)

TXNDC12 inhibits lipid peroxidation and ferroptosis
by: Lanlan Tang, et al.
Published: (2023-12-01)

An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer
by: Gabrielle J. Dardis, et al.
Published: (2023-07-01)

Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma
by: Jessica A. Scarborough, et al.
Published: (2020-07-01)

Chemotherapeutic drug screening in 3D-Bioengineered human myobundles provides insight into taxane-induced myotoxicities
by: Maria J. Torres, et al.
Published: (2022-10-01)

Integrating Systems Biology and an Ex Vivo Human Tumor Model Elucidates PD-1 Blockade Response Dynamics
by: Munisha Smalley, et al.
Published: (2020-06-01)

Newcastle-disease-virus-induced ferroptosis through nutrient deprivation and ferritinophagy in tumor cells
by: Xianjin Kan, et al.
Published: (2021-08-01)

Genetic ablation of ketohexokinase C isoform impairs pancreatic cancer development
by: Ilaria Guccini, et al.
Published: (2023-08-01)

Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma
by: Chuanxu Liu, et al.
Published: (2023-08-01)

ICAM1 antibody drug conjugates exert potent antitumor activity in papillary and anaplastic thyroid carcinoma
by: Peng Zhang, et al.
Published: (2023-08-01)

Frequent loss of FAM126A expression in colorectal cancer results in selective FAM126B dependency
by: Shuang Li, et al.
Published: (2024-05-01)

The integrated landscape of eRNA in gastric cancer reveals distinct immune subtypes with prognostic and therapeutic relevance
by: Xin Hu, et al.
Published: (2022-10-01)

The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis
by: Jennifer C. Coleman, et al.
Published: (2024-04-01)

KLHL7 promotes hepatocellular carcinoma progression and molecular therapy resistance by degrading RASA2
by: Lin Chen, et al.
Published: (2023-06-01)

MicroRNA-31 induced by Fusobacterium nucleatum infection promotes colorectal cancer tumorigenesis
by: Bin Tang, et al.
Published: (2023-05-01)

Germline gene fusions across species reveal the chromosomal instability regions and cancer susceptibility
by: Bo-Wen Zhou, et al.
Published: (2023-12-01)

Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse
by: Guillermo Lorenzo, et al.
Published: (2022-11-01)

Orthogonal Proteomic Platforms and Their Implications for the Stable Classification of High-Grade Serous Ovarian Cancer Subtypes
by: Stefani N. Thomas, et al.
Published: (2020-06-01)

Integrative Analysis of Hypoxia-Associated Signature in Pan-Cancer
by: Qian Zhang, et al.
Published: (2020-09-01)

Identifying Drug Sensitivity Subnetworks with NETPHIX
by: Yoo-Ah Kim, et al.
Published: (2020-10-01)

Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell Carcinomas
by: Saumya Srivastava, et al.
Published: (2020-11-01)

On the Origin of ATP Synthesis in Cancer
by: Thomas N. Seyfried, et al.
Published: (2020-11-01)

KDM5B predicts temozolomide-resistant subclones in glioblastoma
by: Vivien Ullrich, et al.
Published: (2024-01-01)

Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer
by: Zekun Liu, et al.
Published: (2020-07-01)

RNA modification-related genes illuminate prognostic signature and mechanism in esophageal squamous cell carcinoma
by: Hui Han, et al.
Published: (2024-03-01)

Assessing Cell Activities rather than Identities to Interpret Intra-Tumor Phenotypic Diversity and Its Dynamics
by: Laloé Monteiro, et al.
Published: (2020-05-01)

Multi-platform-based characterization of ferroptosis in human colorectal cancer
by: Yafang Zhong, et al.
Published: (2022-08-01)

LAPTM4B-YAP loop feedback amplification enhances the stemness of hepatocellular carcinoma
by: Jianping Liao, et al.
Published: (2023-06-01)

CREB3L4 promotes hepatocellular carcinoma progression and decreases sorafenib chemosensitivity by promoting RHEB-mTORC1 signaling pathway
by: Zhengchen Jiang, et al.
Published: (2024-02-01)

Exosomal MicroRNA signature acts as an efficient biomarker for non-invasive diagnosis of gallbladder carcinoma
by: Pinghua Yang, et al.
Published: (2022-09-01)

Ecological and Evolutionary Consequences of Anticancer Adaptations
by: Justine Boutry, et al.
Published: (2020-11-01)

Signatures of TSPAN8 variants associated with human metabolic regulation and diseases
by: Tisham De, et al.
Published: (2021-08-01)